Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

DC Three minutes and ten seconds into the presentation in May of 2013 William states "We have a patent pending of the combination of bio-markers and one for the algorithm that is used..Here is the patent pending William is referring to. It is owned by Provista Diagnostics. The patent application began on March 31,2011 and then assigned to Provista Diagnostics on March 7, 2013. The patent pending is the only patent found and assigned to Provista Diagnostics..The skeptics cannot disprove this fact..If they do it will be false words and not facts.., They would need to show the patent William is referring to assigned to GCDX to prove their case..That is not going to happen...This is why we believe Provista Diagnostics will merge with Radient..That is why the corporate name Radient Pharmaceuticals in Delaware is available according to living in the past you understand...ahooooololooooo....Wolf

20110077931 METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS - Methods and apparatus for identifying disease status according to various aspects of the present invention include analyzing the levels of one or more biomarkers. The methods and apparatus may use biomarker data for a condition-positive cohort and a condition-negative cohort and select multiple relevant biomarkers from the plurality of biomarkers. The system may generate a statistical model for determining the disease status according to differences between the biomarker data for the relevant biomarkers of the respective cohorts. The methods and apparatus may also facilitate ascertaining the disease status of an individual by producing a composite score for an individual patient and comparing the patient's composite score to one or more thresholds for identifying potential disease status. 03-31-2011

20130060549 METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS -

Methods and apparatus for identifying disease status according to various aspects of the present invention include analyzing the levels of one or more biomarkers. The methods and apparatus may use biomarker data for a condition-positive cohort and a condition-negative cohort and select multiple relevant biomarkers from the plurality of biomarkers. The system may generate a statistical model for determining the disease status according to differences between the biomarker data for the relevant biomarkers of the respective cohorts. The methods and apparatus may also facilitate ascertaining the disease status of an individual by producing a composite score for an individual patient and comparing the patient's composite score to one or more thresholds for identifying potential disease
status. 03-07-2013


Patent application title: METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
Inventors: F. Randall Grimes (Scottsdale, AZ, US) Provista Diagnostics, Inc. (Scottsdale, AZ, US)
Assignees: Provista Diagnostics, Inc.
IPC8 Class: AG06G760FI
USPC Class: 703 11
Class name: Data processing: structural design, modeling, simulation, and emulation simulating nonelectrical device or system biological or biochemical
Publication date: 2013-03-07
Patent application number: 20130060549

Read more: http://www.faqs.org/patents/app/20130060549#ixzz3KQ3uintk

******************************************************************
Patent application number Description Published
20090028786

METHODS AND APPARATUS FOR IMAGING AGENTS FOR DISEASE DETECTION - Methods and apparatus for identifying disease status according to various aspects of the present invention include delivering one or more imaging agents to all or parts of the body for disease observation, screening and/or detection. The methods and apparatus may deliver imaging agents that include any suitable disease-associated compositions, such as riboflavin carrier protein (RCP) and/or RCP modifications and antibodies thereof, labeled with an imaging label. In one embodiment, the imaging agents may be delivered to a selected site or sites in the body and subsequently observed using an imaging method. In another embodiment, the imaging agents may be delivered throughout the body for screening applications. In yet another embodiment, the imaging agents may be delivered throughout the body to detect a reduction and/or increase in cellular metabolism. 01-29-2009

Patents pending Assignees
http://www.faqs.org/patents/asnl/aa

http://www.faqs.org/patents/asnl/pp
Provista Diagnostics, Inc. 2013-03-07 / 20130060549 - METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS 1

Patents pending inventors